Suppr超能文献

Sox2:miR-486-5p 轴通过抑制肿瘤抑制网络调节 GBM 细胞的存活。

A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.

机构信息

Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland.

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Cancer Res. 2020 Apr 15;80(8):1644-1655. doi: 10.1158/0008-5472.CAN-19-1624. Epub 2020 Feb 24.

Abstract

Glioblastoma multiforme (GBM) and other solid malignancies are heterogeneous and contain subpopulations of tumor cells that exhibit stem-like features. Our recent findings point to a dedifferentiation mechanism by which reprogramming transcription factors Oct4 and Sox2 drive the stem-like phenotype in glioblastoma, in part, by differentially regulating subsets of miRNAs. Currently, the molecular mechanisms by which reprogramming transcription factors and miRNAs coordinate cancer stem cell tumor-propagating capacity are unclear. In this study, we identified miR-486-5p as a Sox2-induced miRNA that targets the tumor suppressor genes and and regulates the GBM stem-like cells. miR-486-5p associated with the GBM stem cell phenotype and Sox2 expression and was directly induced by Sox2 in glioma cell lines and patient-derived neurospheres. Forced expression of miR-486-5p enhanced the self-renewal capacity of GBM neurospheres, and inhibition of endogenous miR-486-5p activated PTEN and FoxO1 and induced cell death by upregulating proapoptotic protein BIM via a PTEN-dependent mechanism. Furthermore, delivery of miR-486-5p antagomirs to preestablished orthotopic GBM neurosphere-derived xenografts using advanced nanoparticle formulations reduced tumor sizes and enhanced the cytotoxic response to ionizing radiation. These results define a previously unrecognized and therapeutically targetable Sox2:miR-486-5p axis that enhances the survival of GBM stem cells by repressing tumor suppressor pathways. SIGNIFICANCE: This study identifies a novel axis that links core transcriptional drivers of cancer cell stemness to miR-486-5p-dependent modulation of tumor suppressor genes that feeds back to regulate glioma stem cell survival.

摘要

多形性胶质母细胞瘤(GBM)和其他实体恶性肿瘤是异质的,包含表现出干细胞样特征的肿瘤细胞亚群。我们最近的研究结果表明了一种去分化机制,其中重编程转录因子 Oct4 和 Sox2 通过差异调节 miRNA 的亚群来驱动胶质母细胞瘤中的干细胞样表型。目前,重编程转录因子和 miRNA 协调癌症干细胞肿瘤增殖能力的分子机制尚不清楚。在这项研究中,我们确定了 miR-486-5p 是 Sox2 诱导的 miRNA,其靶向肿瘤抑制基因 和 ,并调节 GBM 干细胞样细胞。miR-486-5p 与 GBM 干细胞表型和 Sox2 表达相关,并且在神经球系中直接由 Sox2 在神经胶质瘤细胞系和患者来源的神经球中诱导。强制表达 miR-486-5p 增强了 GBM 神经球的自我更新能力,而内源性 miR-486-5p 的抑制通过上调促凋亡蛋白 BIM 并通过依赖于 PTEN 的机制诱导细胞死亡来激活 PTEN 和 FoxO1。此外,使用先进的纳米颗粒制剂将 miR-486-5p 反义寡核苷酸递送至预先建立的原位 GBM 神经球衍生异种移植物中,可减少肿瘤大小,并增强对电离辐射的细胞毒性反应。这些结果定义了一个以前未被识别的、可治疗的 Sox2:miR-486-5p 轴,该轴通过抑制肿瘤抑制途径来增强 GBM 干细胞的存活。意义:这项研究确定了一个新的轴,该轴将癌症细胞干性的核心转录驱动因子与 miR-486-5p 依赖性调节肿瘤抑制基因联系起来,这些基因反馈调节调节胶质瘤干细胞的存活。

相似文献

1
A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
Cancer Res. 2020 Apr 15;80(8):1644-1655. doi: 10.1158/0008-5472.CAN-19-1624. Epub 2020 Feb 24.
2
Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
Oncogene. 2016 Sep 15;35(37):4903-13. doi: 10.1038/onc.2016.22. Epub 2016 Feb 22.
3
The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
BMC Cancer. 2021 Nov 19;21(1):1248. doi: 10.1186/s12885-021-08978-z.
4
DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
Oncogene. 2015 Jul 23;34(30):3994-4004. doi: 10.1038/onc.2014.334. Epub 2014 Oct 20.
6
Essential role of METTL3-mediated mA modification in glioma stem-like cells maintenance and radioresistance.
Oncogene. 2018 Jan 25;37(4):522-533. doi: 10.1038/onc.2017.351. Epub 2017 Oct 9.
9
miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Life Sci. 2019 Jun 1;226:98-106. doi: 10.1016/j.lfs.2019.04.023. Epub 2019 Apr 10.
10
FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
PLoS One. 2015 Oct 7;10(10):e0137703. doi: 10.1371/journal.pone.0137703. eCollection 2015.

引用本文的文献

2
Epigenetic Alterations in Glioblastoma Multiforme as Novel Therapeutic Targets: A Scoping Review.
Int J Mol Sci. 2025 Jun 12;26(12):5634. doi: 10.3390/ijms26125634.
4
The Role of miR-486-5p on CSCs Phenotypes in Colorectal Cancer.
Cancers (Basel). 2024 Dec 19;16(24):4237. doi: 10.3390/cancers16244237.
5
Clinical applications of circulating biomarkers in non-small cell lung cancer.
Front Cell Dev Biol. 2024 Aug 21;12:1449232. doi: 10.3389/fcell.2024.1449232. eCollection 2024.
6
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.
Mol Brain. 2024 Jul 2;17(1):42. doi: 10.1186/s13041-024-01113-6.
7
LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B.
J Exp Clin Cancer Res. 2024 May 9;43(1):139. doi: 10.1186/s13046-024-03058-z.
8
Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics.
Cancer Cell Int. 2023 Oct 11;23(1):238. doi: 10.1186/s12935-023-03090-7.
9
Cancer stem cells in brain tumors: From origin to clinical implications.
MedComm (2020). 2023 Aug 9;4(4):e341. doi: 10.1002/mco2.341. eCollection 2023 Aug.
10
SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells.
PLoS Pathog. 2023 Apr 14;19(4):e1011316. doi: 10.1371/journal.ppat.1011316. eCollection 2023 Apr.

本文引用的文献

1
MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.
Biosci Rep. 2019 Jul 15;39(7). doi: 10.1042/BSR20190650. Print 2019 Jul 31.
2
Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis.
NPJ Precis Oncol. 2018 Dec 12;2:28. doi: 10.1038/s41698-018-0071-0. eCollection 2018.
3
The fundamental role of miR-10b in metastatic cancer.
Am J Cancer Res. 2018 Sep 1;8(9):1674-1688. eCollection 2018.
5
Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal.
Biomedicines. 2018 Mar 7;6(1):29. doi: 10.3390/biomedicines6010029.
6
BCL-2 family proteins: changing partners in the dance towards death.
Cell Death Differ. 2018 Jan;25(1):65-80. doi: 10.1038/cdd.2017.186. Epub 2017 Nov 17.
7
miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
Oncol Rep. 2018 Jan;39(1):71-80. doi: 10.3892/or.2017.6064. Epub 2017 Nov 1.
8
BH3-only protein BIM: An emerging target in chemotherapy.
Eur J Cell Biol. 2017 Dec;96(8):728-738. doi: 10.1016/j.ejcb.2017.09.002. Epub 2017 Sep 23.
9
The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways.
Oncotarget. 2017 Aug 24;8(42):72835-72846. doi: 10.18632/oncotarget.20427. eCollection 2017 Sep 22.
10
Direct reprogramming with SOX factors: masters of cell fate.
Curr Opin Genet Dev. 2017 Oct;46:24-36. doi: 10.1016/j.gde.2017.06.005. Epub 2017 Jul 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验